Date of Award:

12-2023

Document Type:

Thesis

Degree Name:

Master of Science (MS)

Department:

Biological Engineering

Committee Chair(s)

Ronald Sims

Committee

Ronald Sims

Committee

Mark Smith

Committee

Anhong Zhou

Abstract

Advancements in technology can improve industrial manufacturing, especially in the biopharmaceutical industry. However, the nascent state of most process technologies are derived from the scale-up of laboratory practices. Such is the case of GMP plasmid DNA manufacturing, which to date, heavily relies on decades old laboratory-scale process technologies to enable large-scale processing. This work explores the possible optimization of those processes through possible implementation of new technologies, such as single-use continuous flow centrifugation, as well as streamlining up-scaled processes, such as microbial resuspension, lysis, and neutralization. New solution recipes were develop and tested and compared to current industry standards. One set of new solution recipes produces less contamination in the pDNA product but produces less pDNA than the current industry standard.

Checksum

84b59db9f441f7b47282b8fd015a6ce1

Available for download on Friday, December 01, 2028

Share

COinS